Inventor · disambiguated record
Atsushi Muto
Also filed as: MUTO ATSUSHI
3 granted patents·13 pending applications·252 citations·filing 2006–2025
77Inventor score
Top patents by PatentIndex Score
16 records- 0196US9334331B2Bispecific antibodiesIGAWA TOMOYUKI·Filed 2011·Granted May 10, 2016·221 cites·33 claims
- 0295US10450381B2Methods of treatment that include the administration of bispecific antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Granted Oct 22, 2019·28 cites·84 claims
- 0392US2025382387A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0489US2024376228A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0588US2024059795A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0684US2023212315A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0783US11214623B2Antibody capable of neutralizing substance having activity alternative to function of coagulation factor VIII (FVIII)CHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Granted Jan 4, 2022·3 cites·10 claims
- 0881US2022267470A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0977US2025154285A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1070US2019315884A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1164US2014370018A1Multi-specific antigen-binding molecules and uses thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 1264US2014037632A1Multi-specific antigen-binding molecules and uses thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 1363US2017022293A1Nucleic acid encoding bispecific antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 1451US2019248921A1Treatment for hemorrhagic diseases by anti-protein-c antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1551US2016229922A1Treatment for hemorrhagic diseases by anti-protein-c antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Application pending·0 cites
- 1643US2008254043A1Drug For Treating Ischemic DiseaseCHUGAI PHARMACEUTICAL CO LTD·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Atsushi Muto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →